Advertisement
Screener

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Other Nonoperating Income (Expense)

2.8 / 5 stars · 68/120 Roast Me

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Other Nonoperating Income (Expense)

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Other Nonoperating Income (Expense) of -$37.41 million for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.

Financial Statements › Income Statement › Other Income

us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-05

  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other nonoperating income (expense) for the quarter ending 2026-06-27 was -$37.41M, a 24392.21% decline year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other nonoperating income (expense) for the quarter ending 2026-03-28 was -$124.13M.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other nonoperating income (expense) for the quarter ending 2025-12-27 was $12.10M.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other nonoperating income (expense) for the quarter ending 2025-09-27 was -$22.62M, a 972.61% decline year-over-year.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other nonoperating income (expense) for fiscal 2025 was -$22.58M.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other nonoperating income (expense) for fiscal 2024 was -$16.52M, a 117.29% decline from fiscal 2023.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other nonoperating income (expense) for fiscal 2023 was $95.54M, a 213.00% increase from fiscal 2022.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other nonoperating income (expense) for fiscal 2022 was $30.52M.
Period endOther Nonoperating Income (Expense) 3 monthOther Nonoperating Income (Expense) 3 month as first filedOther Nonoperating Income (Expense) 6 monthOther Nonoperating Income (Expense) 6 month as first filedOther Nonoperating Income (Expense) 9 monthOther Nonoperating Income (Expense) 9 month as first filedOther Nonoperating Income (Expense) 12 monthOther Nonoperating Income (Expense) 12 month as first filed
2026-06-27-$37.41M
10-Q · filed 2026-08-05
-$161.54M
10-Q · filed 2026-08-05
-$149.44M
derived: sum of 3 quarters · filed 2026-08-05
-$172.06M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-28-$124.13M
10-Q · filed 2026-05-07
-$112.03M
derived: sum of 2 quarters · filed 2026-05-07
-$134.65M
derived: sum of 3 quarters · filed 2026-05-07
-$134.50M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-27$12.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
-$10.52M
derived: sum of 2 quarters · filed 2026-02-18
-$10.37M
derived: sum of 3 quarters · filed 2026-08-05
-$22.58M
10-K · filed 2026-02-18
2025-09-27-$22.62M
10-Q · filed 2025-11-05
-$22.46M
derived: sum of 2 quarters · filed 2026-08-05
-$34.67M
10-Q · filed 2025-11-05
-$57.38M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-28$154.00K
10-Q · filed 2026-08-05
-$12.06M
10-Q · filed 2026-08-05
-$34.76M
derived: sum of 3 quarters · filed 2026-08-05
-$32.17M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-29-$12.21M
10-Q · filed 2026-05-07
-$34.92M
derived: sum of 2 quarters · filed 2026-05-07
-$32.32M
derived: sum of 3 quarters · filed 2026-05-07
-$34.56M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-28-$22.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
-$20.11M
derived: sum of 2 quarters · filed 2026-02-18
-$22.35M
derived: sum of 3 quarters · filed 2026-02-18
-$16.52M
10-K · filed 2026-02-18
2024-09-28$2.59M
10-Q · filed 2025-11-05
$352.00K
derived: sum of 2 quarters · filed 2025-11-05
$6.18M
10-Q · filed 2025-11-05
$113.92M
derived: sum of 4 quarters · filed 2026-02-18
2024-06-29-$2.24M
10-Q · filed 2025-08-06
$3.59M
10-Q · filed 2025-08-06
$111.33M
derived: sum of 3 quarters · filed 2026-02-18
$105.07M
derived: sum of 4 quarters · filed 2026-02-18
2024-03-30$5.83M
10-Q · filed 2025-05-07
$113.57M
derived: sum of 2 quarters · filed 2026-02-18
$107.31M
derived: sum of 3 quarters · filed 2026-02-18
$104.65M
derived: sum of 4 quarters · filed 2026-02-18
2023-12-30$107.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18
$101.48M
derived: sum of 2 quarters · filed 2026-02-18
$98.81M
derived: sum of 3 quarters · filed 2026-02-18
$95.54M
10-K · filed 2026-02-18
2023-09-30-$6.26M
10-Q · filed 2024-11-06
-$8.92M
derived: sum of 2 quarters · filed 2024-11-06
-$12.20M
10-Q · filed 2024-11-06
$103.35M
derived: sum of 4 quarters · filed 2025-02-19
2023-07-01-$2.66M
10-Q · filed 2024-08-07
-$5.94M
10-Q · filed 2024-08-07
$109.61M
derived: sum of 3 quarters · filed 2025-02-19
$92.99M
derived: sum of 4 quarters · filed 2025-02-19
2023-04-01-$3.28M
10-Q · filed 2024-05-09
$112.27M
derived: sum of 2 quarters · filed 2025-02-19
$95.65M
derived: sum of 3 quarters · filed 2025-02-19
$55.87M
derived: sum of 4 quarters · filed 2025-02-19
2022-12-31$115.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19
$98.93M
derived: sum of 2 quarters · filed 2025-02-19
$59.15M
derived: sum of 3 quarters · filed 2025-02-19
$30.52M
10-K · filed 2025-02-19
2022-09-24-$16.62M
10-Q · filed 2023-11-08
-$56.40M
derived: sum of 2 quarters · filed 2023-11-08
-$85.02M
10-Q · filed 2023-11-08
-$82.95M
derived: sum of 4 quarters · filed 2024-02-14
2022-06-25-$39.78M
10-Q · filed 2023-08-09
-$68.41M
10-Q · filed 2023-08-09
-$66.34M
derived: sum of 3 quarters · filed 2024-02-14
-$82.55M
derived: sum of 4 quarters · filed 2024-02-14
2022-03-26-$28.63M
10-Q · filed 2023-05-11
-$26.55M
derived: sum of 2 quarters · filed 2024-02-14
-$42.77M
derived: sum of 3 quarters · filed 2024-02-14
-$36.80M
derived: sum of 4 quarters · filed 2024-02-14
2021-12-25$2.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
-$14.14M
derived: sum of 2 quarters · filed 2024-02-14
-$8.18M
derived: sum of 3 quarters · filed 2024-02-14
-$35.89M
10-K · filed 2024-02-14
2021-09-25-$16.21M
10-Q · filed 2022-11-02
-$10.25M
derived: sum of 2 quarters · filed 2022-11-02
-$37.97M
10-Q · filed 2022-11-02
$38.62M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-26$5.96M
10-Q · filed 2022-08-03
-$21.75M
10-Q · filed 2022-08-03
$54.83M
derived: sum of 3 quarters · filed 2023-02-22
$76.04M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-27-$27.72M
10-Q · filed 2022-05-04
$48.87M
derived: sum of 2 quarters · filed 2023-02-22
$70.08M
derived: sum of 3 quarters · filed 2023-02-22
$96.34M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-26$76.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$97.80M
derived: sum of 2 quarters · filed 2023-02-22
$124.06M
derived: sum of 3 quarters · filed 2023-02-22
$99.98M
10-K · filed 2023-02-22
2020-09-26$21.21M
10-Q · filed 2021-11-03
$47.47M
derived: sum of 2 quarters · filed 2021-11-03
$23.40M
10-Q · filed 2021-11-03
$43.85M
derived: sum of 4 quarters · filed 2022-02-16
2020-06-27$26.26M
10-Q · filed 2021-08-04
$2.19M
10-Q · filed 2021-08-04
$22.64M
derived: sum of 3 quarters · filed 2022-02-16
$8.39M
derived: sum of 4 quarters · filed 2022-02-16
2020-03-28-$24.07M
10-Q · filed 2021-05-04
-$3.62M
derived: sum of 2 quarters · filed 2022-02-16
-$17.87M
derived: sum of 3 quarters · filed 2022-02-16
-$18.08M
derived: sum of 4 quarters · filed 2022-02-16
2019-12-28$20.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16
$6.20M
derived: sum of 2 quarters · filed 2022-02-16
$5.99M
derived: sum of 3 quarters · filed 2022-02-16
$12.29M
10-K · filed 2022-02-16
2019-09-28-$14.25M
10-Q · filed 2020-10-29
-$14.47M
derived: sum of 2 quarters · filed 2020-10-29
-$8.16M
10-Q · filed 2020-10-29
-$18.97M
derived: sum of 4 quarters · filed 2021-02-17
2019-06-29-$213.00K
10-Q · filed 2020-08-05
$6.09M
10-Q · filed 2020-08-05
-$4.72M
derived: sum of 3 quarters · filed 2021-02-17
$1.19M
derived: sum of 4 quarters · filed 2021-02-17
2019-03-30$6.31M
10-Q · filed 2020-05-07
-$4.50M
derived: sum of 2 quarters · filed 2021-02-17
$1.41M
derived: sum of 3 quarters · filed 2021-02-17
$13.44M
derived: sum of 4 quarters · filed 2021-02-17
2018-12-29-$10.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17
-$4.90M
derived: sum of 2 quarters · filed 2021-02-17
$7.14M
derived: sum of 3 quarters · filed 2021-02-17
$13.26M
10-K · filed 2021-02-17
2018-09-29$5.91M
10-Q · filed 2019-11-06
$17.95M
derived: sum of 2 quarters · filed 2019-11-06
$24.07M
10-Q · filed 2019-11-06
$37.83M
derived: sum of 4 quarters · filed 2020-02-11
2018-06-30$12.04M
10-Q · filed 2019-07-31
$18.16M
10-Q · filed 2019-07-31
$31.91M
derived: sum of 3 quarters · filed 2020-02-11
$38.33M
derived: sum of 4 quarters · filed 2020-02-11
2018-03-31$6.12M
10-Q · filed 2019-05-07
$19.88M
derived: sum of 2 quarters · filed 2020-02-11
$26.29M
derived: sum of 3 quarters · filed 2020-02-11
$28.76M
derived: sum of 4 quarters · filed 2020-02-11
2017-12-30$13.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11
$20.17M
derived: sum of 2 quarters · filed 2020-02-11
$22.64M
derived: sum of 3 quarters · filed 2020-02-11
$37.76M
10-K · filed 2020-02-11
$38.54M
10-K · filed 2018-02-13
2017-09-30$6.41M
10-Q · filed 2018-11-07
$6.49M
10-Q · filed 2017-11-09
$8.88M
derived: sum of 2 quarters · filed 2018-11-07
$24.00M
10-Q · filed 2018-11-07
$24.69M
10-Q · filed 2017-11-09
$25.71M
derived: sum of 4 quarters · filed 2019-02-13
2017-07-01$2.47M
10-Q · filed 2018-08-08
$2.85M
10-Q · filed 2017-08-09
$17.59M
10-Q · filed 2018-08-08
$18.20M
10-Q · filed 2017-08-09
$19.30M
derived: sum of 3 quarters · filed 2019-02-13
$20.32M
derived: sum of 4 quarters · filed 2019-02-13
2017-04-01$15.12M
10-Q · filed 2018-05-10
$15.36M
10-Q · filed 2017-05-10
$16.83M
derived: sum of 2 quarters · filed 2019-02-13
$17.84M
derived: sum of 3 quarters · filed 2019-02-13
$22.86M
derived: sum of 4 quarters · filed 2019-02-13
2016-12-31$1.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13
$2.72M
derived: sum of 2 quarters · filed 2019-02-13
$7.74M
derived: sum of 3 quarters · filed 2019-02-13
$11.76M
10-K · filed 2019-02-13
$11.90M
10-K · filed 2017-02-14
2016-09-24$1.02M
10-Q · filed 2017-11-09
$6.03M
derived: sum of 2 quarters · filed 2017-11-09
$10.06M
10-Q · filed 2017-11-09
$11.32M
derived: sum of 4 quarters · filed 2018-02-13
2016-06-25$5.02M
10-Q · filed 2017-08-09
$9.04M
10-Q · filed 2017-08-09
$10.30M
derived: sum of 3 quarters · filed 2018-02-13
$11.69M
derived: sum of 4 quarters · filed 2018-02-13
2016-03-26$4.03M
10-Q · filed 2017-05-10
$5.29M
derived: sum of 2 quarters · filed 2018-02-13
$6.67M
derived: sum of 3 quarters · filed 2018-02-13
$15.35M
derived: sum of 4 quarters · filed 2018-02-13
2015-12-26$1.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13
$2.65M
derived: sum of 2 quarters · filed 2018-02-13
$11.32M
derived: sum of 3 quarters · filed 2018-02-13
$3.01M
10-K · filed 2018-02-13
2015-09-26$1.39M
10-Q · filed 2016-11-02
$10.06M
derived: sum of 2 quarters · filed 2016-11-02
$1.75M
10-Q · filed 2016-11-02
$3.60M
derived: sum of 4 quarters · filed 2017-02-14
2015-06-27$8.67M
10-Q · filed 2016-08-03
$359.00K
10-Q · filed 2016-08-03
$2.21M
derived: sum of 3 quarters · filed 2017-02-14
$2.54M
derived: sum of 4 quarters · filed 2017-02-14
2015-03-28-$8.31M
10-Q · filed 2016-05-04
-$6.47M
derived: sum of 2 quarters · filed 2017-02-14
-$6.13M
derived: sum of 3 quarters · filed 2017-02-14
-$3.47M
derived: sum of 4 quarters · filed 2017-02-14
2014-12-27$1.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14
$2.18M
derived: sum of 2 quarters · filed 2017-02-14
$4.84M
derived: sum of 3 quarters · filed 2017-02-14
$10.72M
10-K · filed 2017-02-14
2014-09-27$331.00K
10-Q · filed 2015-11-04
$3.00M
derived: sum of 2 quarters · filed 2015-11-04
$8.87M
10-Q · filed 2015-11-04
$9.95M
derived: sum of 4 quarters · filed 2016-02-12
2014-06-28$2.67M
10-Q · filed 2015-07-30
$8.54M
10-Q · filed 2015-07-30
$9.61M
derived: sum of 3 quarters · filed 2016-02-12
$13.67M
derived: sum of 4 quarters · filed 2016-02-12
2014-03-29$5.88M
10-Q · filed 2015-04-30
$6.95M
derived: sum of 2 quarters · filed 2016-02-12
$11.01M
derived: sum of 3 quarters · filed 2016-02-12
$11.97M
derived: sum of 4 quarters · filed 2016-02-12
2013-12-28$1.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12
$5.13M
derived: sum of 2 quarters · filed 2016-02-12
$6.10M
derived: sum of 3 quarters · filed 2016-02-12
$7.17M
10-K · filed 2016-02-12
2013-09-28$4.06M
10-Q · filed 2014-10-30
$5.03M
derived: sum of 2 quarters · filed 2014-10-30
$6.09M
10-Q · filed 2014-10-30
$5.41M
derived: sum of 4 quarters · filed 2015-02-17
2013-06-29$967.00K
10-Q · filed 2014-08-07
$2.04M
10-Q · filed 2014-08-07
$1.35M
derived: sum of 3 quarters · filed 2015-02-17
$459.00K
derived: sum of 4 quarters · filed 2015-02-17
2013-03-30$1.07M
10-Q · filed 2014-04-30
$384.00K
derived: sum of 2 quarters · filed 2015-02-17
-$508.00K
derived: sum of 3 quarters · filed 2015-02-17
-$1.85M
derived: sum of 4 quarters · filed 2015-02-17
2012-12-29-$684.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17
-$1.58M
derived: sum of 2 quarters · filed 2015-02-17
-$2.92M
derived: sum of 3 quarters · filed 2015-02-17
-$3.27M
10-K · filed 2015-02-17
2012-09-29-$892.00K
10-Q · filed 2013-10-30
-$2.24M
derived: sum of 2 quarters · filed 2013-10-30
-$2.58M
10-Q · filed 2013-10-30
-$1.90M
derived: sum of 4 quarters · filed 2014-02-25
2012-06-30-$1.35M
10-Q · filed 2013-07-31
-$1.69M
10-Q · filed 2013-07-31
-$1.01M
derived: sum of 3 quarters · filed 2014-02-25
-$1.76M
derived: sum of 4 quarters · filed 2014-02-25
2012-03-31-$344.00K
10-Q · filed 2013-05-08
$337.00K
derived: sum of 2 quarters · filed 2014-02-25
-$410.00K
derived: sum of 3 quarters · filed 2014-02-25
-$818.00K
derived: sum of 4 quarters · filed 2014-02-25
2011-12-31$681.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
-$66.00K
derived: sum of 2 quarters · filed 2014-02-25
-$474.00K
derived: sum of 3 quarters · filed 2014-02-25
-$411.00K
10-K · filed 2014-02-25
2011-09-24-$747.00K
10-Q · filed 2012-11-01
-$1.16M
derived: sum of 2 quarters · filed 2012-11-01
-$1.09M
10-Q · filed 2012-11-01
$281.00K
derived: sum of 4 quarters · filed 2013-02-27
2011-06-25-$408.00K
10-Q · filed 2012-08-07
-$345.00K
10-Q · filed 2012-08-07
$1.03M
derived: sum of 3 quarters · filed 2013-02-27
-$620.00K
derived: sum of 4 quarters · filed 2013-02-27
2011-03-26$63.00K
10-Q · filed 2012-05-04
$1.44M
derived: sum of 2 quarters · filed 2013-02-27
-$212.00K
derived: sum of 3 quarters · filed 2013-02-27
-$946.00K
derived: sum of 4 quarters · filed 2013-02-27
2010-12-25$1.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27
-$275.00K
derived: sum of 2 quarters · filed 2013-02-27
-$1.01M
derived: sum of 3 quarters · filed 2013-02-27
-$1.48M
10-K · filed 2013-02-27
2010-09-25-$1.65M
10-Q · filed 2011-11-02
-$1.65M
10-Q · filed 2010-11-04
-$2.38M
derived: sum of 2 quarters · filed 2011-11-02
-$2.85M
10-Q · filed 2011-11-02
-$2.79M
10-Q · filed 2010-11-04
-$3.52M
derived: sum of 4 quarters · filed 2012-02-27
2010-06-26-$734.00K
10-Q · filed 2011-08-03
-$736.00K
10-Q · filed 2010-08-03
-$1.20M
10-Q · filed 2011-08-03
-$1.15M
10-Q · filed 2010-08-03
-$1.87M
derived: sum of 3 quarters · filed 2012-02-27
-$591.00K
derived: sum of 4 quarters · filed 2012-02-27
2010-03-27-$468.00K
10-Q · filed 2011-05-04
-$1.14M
derived: sum of 2 quarters · filed 2012-02-27
$143.00K
derived: sum of 3 quarters · filed 2012-02-27
$1.71M
derived: sum of 4 quarters · filed 2012-02-27
2009-12-26-$670.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27
$611.00K
derived: sum of 2 quarters · filed 2012-02-27
$2.18M
derived: sum of 3 quarters · filed 2012-02-27
$1.91M
10-K · filed 2012-02-27
2009-09-26$1.28M
10-Q · filed 2010-11-04
$2.85M
derived: sum of 2 quarters · filed 2010-11-04
$2.58M
10-Q · filed 2010-11-04
2009-06-27$1.56M
10-Q · filed 2010-08-03
$1.30M
10-Q · filed 2010-08-03
2008-12-27-$5.15M
10-K · filed 2011-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71